Skip to main content

What the FDA labels say about taking them together

Buspirone and haloperidol

Buspirone's FDA label of December 22, 2023 names haloperidol in its drug interactions section; the haloperidol labels PlainMeds reads (2) do not name buspirone. The buspirone label: “Haloperidol In a study in normal volunteers, concomitant administration of buspirone and haloperidol resulted in increased serum haloperidol concentrations.”

Check it at the source: the buspirone FDA label on DailyMed (effective December 22, 2023, Unichem Pharmaceuticals (USA), Inc.); the haloperidol FDA label on DailyMed (effective April 23, 2026, PD-Rx Pharmaceuticals, Inc.).

What does the buspirone label say about haloperidol?

Buspirone label, drug interactions

Haloperidol In a study in normal volunteers, concomitant administration of buspirone and haloperidol resulted in increased serum haloperidol concentrations.

Source: FDA drug label (Buspirone Hydrochloride), Unichem Pharmaceuticals (USA), Inc., effective December 22, 2023 (SPL set a6bdf140-075e-445e-a62d-633a4b97f3a8), via openFDA; the full label on DailyMed

What does the haloperidol label say about buspirone?

Haloperidol's label (effective April 23, 2026) and its 1 other brand-application label do not name buspirone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Haloperidol), PD-Rx Pharmaceuticals, Inc., effective April 23, 2026 (SPL set 533b0b4c-cbd6-4ec0-a333-8b04b5b43a1d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

47Buspirone generic labelers
41Haloperidol generic labelers
BuspironeHaloperidol
Labeled forAnxietySchizophrenia
Boxed warningNoYes
Pharmacy cost (NADAC)$0.043 per tablet 15 mg tablet$15.60 per mL 100 mg/mL vial
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?